Cargando…

Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants

INTRODUCTION: Medial temporal lobe (MTL) uptake on tau–positron emission tomography (PET) is seen not only in Alzheimer's disease (AD) dementia but also in the aging population. The relationship of these findings to the development of AD dementia needs to be better understood. METHODS: Tau-PET...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowe, Val J., Bruinsma, Tyler J., Min, Hoon-Ki, Lundt, Emily S., Fang, Ping, Senjem, Matthew L., Boeve, Bradley F., Josephs, Keith A., Pandey, Mukesh K., Murray, Melissa E., Kantarci, Kejal, Jones, David T., Schwarz, Christopher G., Knopman, David S., Petersen, Ronald C., Jack, Clifford R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956801/
https://www.ncbi.nlm.nih.gov/pubmed/29780865
http://dx.doi.org/10.1016/j.dadm.2018.01.005
Descripción
Sumario:INTRODUCTION: Medial temporal lobe (MTL) uptake on tau–positron emission tomography (PET) is seen not only in Alzheimer's disease (AD) dementia but also in the aging population. The relationship of these findings to the development of AD dementia needs to be better understood. METHODS: Tau-PET with AV-1451 was performed on 576 cognitively unimpaired (CU) participants aged 50–94 years. The number of CUs with and without abnormal MTL regions and those with or without extra-MTL abnormalities was determined. Left and right regions were compared within each subject. RESULTS: Of CUs, 58% (334/576) had abnormal tau-PET findings. MTL abnormalities were present in 41% (238/576) of subjects. DISCUSSION: MTL tau-PET signal is often associated with abnormal extra-MTL tau-PET signal in CU participants and may represent neurofibrillary tangle development that could identify participants most likely to develop AD dementia. Tau-PET signal exclusively outside of the MTL is seen in 17% of CU participants and could be the initial findings in participants in different AD dementia pathways. Significant (P < .001) differences in tau–standardized uptake value ratio between sides were noted in 26 of 41 examined brain regions implicating further study of side-specific deficits.